Register
Login:
Share:
Email Facebook Twitter

SAR Share Chat - RSS Feed

Sareum Share Chat (SAR)



Share Price: 0.55Bid: 0.50Ask: 0.60Change: 0.00 (0.00%)No Movement on Sareum
Spread: 0.10Spread as %: 20.00%Open: 0.55High: 0.55Low: 0.525Yesterday’s Close: 0.55



Share Discussion for Sareum (SAR)


Thread ViewThread View
Please Login or Register to post messages
Posts per page:


gekgo
Posts: 68
Off Topic
Opinion:No Opinion
Price:0.55
sky news
26 Feb '14
sorry ment about
 
gekgo
Posts: 68
Off Topic
Opinion:No Opinion
Price:0.55
sky news
26 Feb '14
something coming up at cancer treatment
richardmarshall
Posts: 105
Off Topic
Opinion:No Opinion
Price:0.55
Tim
26 Feb '14
Good scientist crap business man. Somes comments about him stepping back and letting someone else give it a crack might not be a bad idea. He has failed to lift thr share price with his so called good rns. He should have remained a scientist! Now we all have to sit around for another three years hoping 1p will return. This will probably go back to the 0.4-0.5 range where to be honest it belongs! Until the wedge comes in that is.
newblood
Posts: 629
Off Topic
Opinion:No Opinion
Price:0.55
lol
26 Feb '14
i was not expecting owt cracking to be honest. gone have the days when i await a rns at 7am.
time = bell
everybodyelse
Posts: 203
Observation
Opinion:No Opinion
Price:0.55
SP
26 Feb '14
So we're down 15% and considering how few trades there have been this morning I think people are getting worried about nothing. I'm willing to bet the SP will recover tomorrow if not this afternoon.
jamster
Posts: 1,571
Off Topic
Opinion:No Opinion
Price:0.55
Oh dear
26 Feb '14
Yet another "great" RNS and look at how its greeted. He really did f uck up with the whole 2012 thing. There have been so many "good/great" RNS coming out of SAR over the last year that have been completely marred by the sh itstorm Tim created a couple of years back. As I've said before, this ain't going nowhere until he starts bringing in the greenbacks.
enyaw1
Posts: 146
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.60
share price
26 Feb '14
I am afraid that the elephant in the room which has broken the trust of the market in this company is Tim Mitchells comments relating to a takeover/buyout call it what you will by the end of 2012. Since then this has continued an inexorable decline. It will not make significant headway until or if the trust of the market is restored IMO. I have been a long term holder and my investment has been decimated. I now have to hold but I think that we will not see any return for a very long time.
Num4
Posts: 553
Observation
Opinion:Hold
Price:0.60
The right priorities
26 Feb '14
Not convinced by his priorities to be honest. The market has become sick of these types of updates, maybe originally his strategy was correct however the self inflicted damage that was created in 2012 has seen us wither away. Strategy needs to change to restore market confidence in a profitable licence deal and being in the black and not the red before we will see confidence restored. At first opportunity I would be happy with selling off TYK2, restore confidence and the future updates for our blockbuster of Chk1 and Aurora+FLT3 will have the market reaction we all expect and deserve. Give up 1 compound to prove a point and restore market confidence, as stated they are now looking to work on new compounds and expand the pipeline so giving one up is better for our current position.
All IMO
Hopkirk
Posts: 1,091
Off Topic
Opinion:No Opinion
Price:0.60
View Thread (2)
RE: what did I learn today
26 Feb '14
Londonwolfie / TalkingSense. Agreed.

It's all about risk. Progress is good but it will need to remove some of the risk before we see a decent rise. I may have mentioned this a few times lately :)

All of the risks remain. Toxicology, manufacture, leading to paperwork and the trials probably in Q1 both here and China. None of this has been reduced as a result of todays announcements. But if and when each risk is removed we will see a price rise. Smallish steps at first (after any volatility settles down) but getting larger with the removal of each risk.

For me, one of the biggest non-science risks is the cost of Phase 1. SARs payment of £800k is for the pre-clinical work. BACIT have stated they expect to pay the same plus another £1.2m at some point. I can't see any reason to discount the possibility that SAR will need to find a similar amount for CHK1. I hope this isn't by another placing in the latter half of the year but there are other possibilities.

I think Tim is in an awkward (yet good) position whereby he knows the full potential of CHK1 and Aurora FLT3 and really does not want to deal on these before the Phase 1 trial results are known for less than he believes they are worth. If it works out it will see any potential deal command a very significant price. If it doesn't then with hindsight it will be the wrong strategy but that's life. But this 'licence at a later stage' approach costs money which has to come from somewhere.

If not a placing, then he has to deal on something else. Maybe some interest in TYK2/ JAK1 will come out of the conferences and he can licence that programme to cover the costs.

All IMO
wintzy
Posts: 222
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.60
maytheforce
26 Feb '14
Is this connected to SAR?



Share Trading BrochureRequest your Free brochures on share dealing, spread betting and CFDs

Sign up for Live Prices
Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.